About MEAJO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions to authors | Online submission | Subscribe | Advertise | Contact | Login 
Middle East African Journal of Ophthalmology Middle East African Journal of Ophthalmology
Users Online: 380   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others

UPDATES IN CLINICAL TRIALS IN RETINA

Management of neovascular Age-related macular degeneration: A review on landmark randomized controlled trials

Agarwal Aniruddha, Aggarwal Kanika, Gupta Vishali

Year : 2016| Volume: 23| Issue : 1 | Page no: 27-37

   This article has been cited by
 
1 Können digitale Instrumente wie die Makula-App die AMD-Therapie unterstützen?
Anke Tripp, Sarah Brink, Klaus Dieter Lemmen, Peter Mussinghoff, Daniel Pauleikhoff
Klinische Monatsblätter für Augenheilkunde. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 A 3D finite element model to study the cavitation induced stresses on blood–vessel wall during the ultrasound-only phase of photo-mediated ultrasound therapy
Rohit Singh, Xinmai Yang
AIP Advances. 2022; 12(4): 045020
[Pubmed]  [Google Scholar] [DOI]
3 Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration
Se Joon Woo, Miroslav Veith, Jan Hamouz, Jan Ernest, Dominik Zalewski, Jan Studnicka, Attila Vajas, Andras Papp, Vogt Gabor, James Luu, Veronika Matuskova, Young Hee Yoon, Tamás Pregun, Taehyung Kim, Donghoon Shin, Neil M. Bressler
JAMA Ophthalmology. 2021; 139(1): 68
[Pubmed]  [Google Scholar] [DOI]
4 Long-term multimodal imaging characterization of persistent retinal neovascularization using DL-alpha-aminoadipic acid in pigmented and white rabbits
Yixin Yu, Yu Qin, Julia Fu, Yanxiu Li, Wei Zhang, Tianye Zhu, Longtan Jiang, Xueding Wang, Yannis M. Paulus
Experimental Eye Research. 2021; 207: 108577
[Pubmed]  [Google Scholar] [DOI]
5 Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration
Nathan C. Steinle, Weiming Du, Andrea Gibson, Namrata Saroj
Ophthalmology Retina. 2021; 5(2): 141
[Pubmed]  [Google Scholar] [DOI]
6 Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes
Neil M Bressler, Miroslav Veith, Jan Hamouz, Jan Ernest, Dominik Zalewski, Jan Studnicka, Attila Vajas, András Papp, Gabor Vogt, James Luu, Veronika Matuskova, Young Hee Yoon, Tamás Pregun, Taehyung Kim, Donghoon Shin, Inkyung Oh, Hansol Jeong, Mercy Yeeun Kim, Se Joon Woo
British Journal of Ophthalmology. 2021; : bjophthalm
[Pubmed]  [Google Scholar] [DOI]
7 Pachychoroid neovasculopathy: A comparative review on pathology, clinical features, and therapy
Pradeep Sagar, Preetkanwar Singh Sodhi, Sangeeta Roy, Brijesh Takkar, Shorya Vardhan Azad
European Journal of Ophthalmology. 2021; : 1120672121
[Pubmed]  [Google Scholar] [DOI]
8 Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized, phase IIIb OCTAVE study
Giovanni Staurenghi, Justus G. Garweg, Bianca S. Gerendas, Wayne Macfadden, Boris Gekkiev, Philippe Margaron, Cornelia Dunger-Baldauf, Petr Kolar
BMC Ophthalmology. 2020; 20(1)
[Pubmed]  [Google Scholar] [DOI]
9 Sustained drug delivery for glaucoma
Ahmad A. Aref
Current Opinion in Ophthalmology. 2017; 28(2): 169
[Pubmed]  [Google Scholar] [DOI]

 

Read this article